Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy.
Bashair M MussaAnkita SrivastavaAbeer Al-HabshiAbdul Khader MohammedRabih HalwaniSalah AbusnanaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
The key finding of the present study is the significant elevation in levels of MCP-1 in T2DM patients with DNP compared to the patients without DNP and IL-8 and TGF-β were strong predictors of MCP-1 increased levels.